Viking® ( (NYSE: VIK) today announced the Explorers’ Sale, providing North American travelers with new booking incentives ...

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced the ...

Viking Therapeutics (VKTX) has received a new Buy rating, initiated by Stifel Nicolaus analyst, Annabel Samimy.Stay Ahead of the ...

Located in the Culver City Hills, next to a state park. The amazing property is off a private road behind its own security ...

Much of the archdiocese has been left reeling amid the fires, which have destroyed blocks of homes in the city and left ...

JPMorgan highlights valuation resets for Viking and Structure Therapeutics, citing opportunities in T2D/obesity and competitive clinical data insights.

Numerous Norse heritage preservation organizations have built authentic replicas of Viking ships. Embarking on a journey aboard these vessels offers a unique glimpse into the advanced maritime ...

Lessons in Creativity and Innovation from the Notes of Brilliant Thinkers by Jillian Hess, a professor of English at the City ...

Chicago, IL – January 2, 2024 – Zacks.com announces the list of stocks and featured in the Analyst Blog. Every day the Zacks ...

Viking has announced the launch of its Explorers' Sale, providing North American travelers with new booking incentives across ...

Viking Holdings Ltd (VIK) stock saw a modest uptick, ending the day at $43.05 which represents a slight increase of $0.44 or 1.03% from the prior close of $42.61. The stock opened at $42.46 and ...